|
ATF1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.63309996029193E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.73860004171189E-09 |
| Normal-vs-Stage2 |
1.823110E-04 |
| Normal-vs-Stage3 |
2.198900E-03 |
| Normal-vs-Stage4 |
3.295000E-01 |
| Stage1-vs-Stage2 |
9.336000E-01 |
| Stage1-vs-Stage3 |
2.792800E-01 |
| Stage1-vs-Stage4 |
1.472040E-01 |
| Stage2-vs-Stage3 |
3.852000E-01 |
| Stage2-vs-Stage4 |
1.698020E-01 |
| Stage3-vs-Stage4 |
4.415200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.78320003207944E-09 |
| Normal-vs-AfricanAmerican |
3.69900000000145E-05 |
| Normal-vs-Asian |
2.051800E-01 |
| Caucasian-vs-AfricanAmerican |
6.079200E-01 |
| Caucasian-vs-Asian |
6.947400E-01 |
| AfricanAmerican-vs-Asian |
8.407000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.11829997986968E-10 |
| Normal-vs-Female |
1.177140E-03 |
| Male-vs-Female |
1.892100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.74309999999767E-05 |
| Normal-vs-Extreme_Weight |
4.76189976339469E-10 |
| Normal-vs-Obese |
5.9170999999969E-05 |
| Normal-vs-Extreme_Obese |
3.89980000000678E-05 |
| Normal_Weight-vs-Extreme_Weight |
4.416400E-01 |
| Normal_Weight-vs-Obese |
4.794000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.981400E-01 |
| Extreme_Weight-vs-Obese |
8.438000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.938400E-01 |
| Obese-vs-Extreme_Obese |
3.234800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.018500E-03 |
| Normal-vs-Age(41-60Yrs) |
6.87630000051342E-07 |
| Normal-vs-Age(61-80Yrs) |
1.51180001850548E-09 |
| Normal-vs-Age(81-100Yrs) |
1.997950E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.402400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.217400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.047420E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.575850E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.910390E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.337800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.17639994914975E-09 |
| Normal-VS-Type2 PRCC |
2.38369999960852E-07 |
| Normal-VS-KIRP CIMP |
1.394590E-01 |
| Normal-VS-Unclassified PRCC |
4.277500E-03 |
| Type1 PRCC-VS-Type2 PRCC |
9.737600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.501800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.496800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.469800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.845000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.428000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.15229994621802E-10 |
| Normal-vs-N1 |
3.723800E-01 |
| Normal-vs-N2 |
1.722510E-03 |
| N0-vs-N1 |
6.683200E-03 |
| N0-vs-N2 |
9.056000E-01 |
| N1-vs-N2 |
2.488600E-01 |
|
|
